About this trial
This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.
Eligibility criteria
Qualifiers
Adults aged 18-65 years
Diagnosis of episodic high-frequency migraine according to ICHD criteria
Diagnosis confirmed by a neurologist
At least 1-year history of migraine
Disqualifiers
Other significant neurological disorders
Severe psychiatric conditions affecting participation
Medical contraindications to moderate physical activity
Chronic migraine (≥15 headache days/month)
Trial design
Treatments tested in this trial
- Control group (receiving standard medical therapy alone)
- Hatha yoga